Profile image
Story Views

Last Hour:
Last 24 Hours:

Private Equity and Venture Capital Funding for Healthcare

Friday, January 6, 2017 7:18
% of readers think this story is Fact. Add your two cents.

(Before It's News)

This report provides in-depth qualitative and quantitative analyses of global and regional trends that have shaped the current healthcare PE and VC landscape, particularly from 2006 to 2015. It provides multilevel analyses that identify geographical markets and therapy areas attracting noteworthy investments. Analyses of key investment indicators in the US, including levels of fundraising activities by PE and VC companies, VC investments by industry sector, and VC-backed exits and venture financing trends – particularly for early-stage healthcare companies – are also included.

Information from our robust, industry-leading databases shows that global values of completed equity offerings in the healthcare industry are continuing their upward trend, reaching record highs in recent years. Quantitative analyses of equity offerings in the healthcare sector from 2006 to 2015 are provided alongside trends in healthcare VC-backed initial public offerings (IPOs) in the US. Top healthcare IPOs are reviewed in detail, with company profiles that include product pipelines showing therapy areas of focus, indications and product development stages.

For more information about this report at


- How important are PE and VC funds to the future development of the healthcare industry?

- How does the venture-backed healthcare innovation model work?

- What have been the global trends in healthcare PE and VC over the last decade in terms of deal activity (volume) and value?

- Which geographical markets are attracting noteworthy healthcare investments from PE and VC firms, and which will drive investments in the future?

- Which therapy areas attracted the most PE and VC investments by value in the last two years and what are the reasons for these trends?

- How much capital did the top healthcare PE and VC deals raise in 2015, and which investment and healthcare companies were involved?

- What are the new financing models being adopted by early-stage healthcare companies in the face of the declining availability of VC funds?

- How did the 2008 global financial crisis affect VC and PE investments in healthcare, in both the short and longer term?

- How is the healthcare industry performing compared with other industry sectors in terms of attracting VC investments in the US?

- What are the risks if investments in the healthcare industry decrease significantly?

- How are VC firms likely to react to increasing competition in the healthcare sector in the coming years?

- What specific factors will continue to drive investment in the healthcare industry in the coming years?

Request a sample copy at

Reasons to buy

This report will allow you to -

- Gain insightful analyses and understanding of PE and VC dynamics in the healthcare industry. The report comprehensively describes and assesses the most important factors driving and restraining investments in this industry by assessing key investment information and parameters over the last decade.

- Assess quantitative and qualitative trends shaping deal activity in the healthcare sector. Publisher employed a multi-faceted research approach that involved the analysis of a variety of secondary research sources and the interrogation of proprietary databases, to provide a complete and objective view of industry and investment dynamics.

- Gain insight on upcoming trends and factors influencing global healthcare investments.

Tables of Content:

Table 1: Main Differences and Similarities between Private Equity and Venture Capital Companies 8

Table 2: Types of Private Equity Firms Typically Operating in the Healthcare Industry 12

Table 3: Top 10 Healthcare Private Equity Deals in 2015 18

Table 4: Top 10 Healthcare Venture Capital Deals in 2015 19

Table 5: Emerging Sources of Funding for Early-Stage Healthcare Companies 21

Table 6: Venture Capital Investment in the US Life Sciences Industry, 2006-2015 ($m) 27

Table 7: Top 10 Healthcare IPOs in 2015 32

Table 8: Axovant Product Pipeline 33

Table 9: NantKwest Product Pipeline 34

Table 10: Adaptimmune Therapeutics Product Pipeline 35

Table 11: Spark Therapeutics Product Pipeline 36

Table 12: Aimmune Therapeutics Product Pipeline 37

Table 13: Blueprint Medicines Product Pipeline 38

Table 14: RegenxBio Product Pipeline 39

Table 15: ProNAi Product Pipeline 40

Table 16: Seres Therapeutics Product Pipeline 41

Table 17: Global Blood Therapeutics Product Pipeline 42

Table 18: TPG Capital, Healthcare Investment Portfolio, 2016 44

Table 19: The Carlyle Group, Healthcare Investment Portfolio, 2016 46

Table 20: Apax Partners, Healthcare Investment Portfolio, 2016 47

Table 21: KKR & Co, Healthcare Investment Portfolio, 2016 49

Table 22: Warburg Pincus, Healthcare Investment Portfolio, 2016 50

Table 23: Bain Capital Private Equity, Healthcare Investment Portfolio, 2016 51

Table 24: New Enterprise Associates, Healthcare Investment Portfolio, 2016 52

Table 25: OrbiMed Advisors, Selected Healthcare Investments 55

Table 26: Kleiner Perkins Caufield & Byers, Selected Healthcare Investments 58

Table 27: Flagship Ventures, Selected Healthcare Investments 60

Table 28: Third Rock Investments, Selected Healthcare Investments 62

Table 29: Versant Ventures, Selected Healthcare Investments 64

 Ask for Discount at

Contact Us:                 
Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.